Topics

Companies Related to "Characterization optimization endogenous lipid accumulation Chlorella vulgaris SDEC" [Most Relevant Company Matches] RSS

04:42 EDT 4th April 2020 | BioPortfolio

Here are the most relevant search results for "Characterization optimization endogenous lipid accumulation Chlorella vulgaris SDEC" found in our extensive corporate database of over 50,000 company records.

Showing "Characterization optimization endogenous lipid accumulation Chlorella vulgaris SDEC" Companies 1–25 of 516

Extremely Relevant

Sun Chlorella Corporation

Sun Chlorella USA is a privately owned developer, manufacturer and distributor of premium chlorella and herbal products. For more than 40 years, Sun Chlorella Corp. has been a leader in the nutritional supplement industry and is one of the most trusted and respected brands due to its focus on research, innovation and delivery of high quality dietary supplements. Sun Chlorella Corp. holds the paten...


Sun Chlorella USA

Chlorella are fresh-water green algae that contain the highest chlorophyll content of any known plant, as well as exceptionally high concentrations of essential vitamins, minerals, dietary fiber, nucleic acids, amino acids and enzymes. Sun Chlorella "A" tablets are produced using the company's patented pulverization process, which results in superior nutrient absorption.

Relevant

National Lipid Association

The National Lipid Association (NLA) is a multidisciplinary non-profit membership association that serves the community of healthcare professionals who manage patients with lipid disorders and cardiovascular disease. The NLA’s public health mission is to help reduce deaths related to high cholesterol. For more information, please see the NLA Web site ...


Eurofins Spinnovation Analytical B.V.

Spinnovation Biologics is a division of Spinnovation Analytical BV (Nijmegen, The Netherlands, www.spinnovation-analytical.com). Spinnovation is a <!--LGfEGNT2Lhm-->contract research organization expert in delivering analytical service to the Industry (Pharmaceuticals, Chemicals/Polymers, <!--LGfEGNT2Lhm-->Food Products). Its expertise and core activity focuses on the use of Nuclea...

The Foundation of the National Lipid Association

Founded in 2002, the 3,000 members of the National Lipid Association — a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine — share a common goal: to enhance the practice of lipid management in clinical medicine and to reduce the morbidity and mortality associated with atherosclerotic ...

CherylLeeMD® Sensitive Skin Care

CherylLeeMD® Sensitive Skin Care products are the first skin care products to work with the skin to obtain its optimal equilibrium by simultaneously addressing skin lipid deficiencies, skin pH, inflammation, cellular turnover, and chemical sensitivities and toxicities. The technology behind this product line is the patent-pending TrueLipids® Technolo...

Cellectar, Inc.

Cellectar, Inc. is a clinical stage radiopharmaceutical company that designs, develops and manufactures products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs) analogs, with radioisotopes that can either image or destroy malignant cells. Cellectar's products' unique mechanism of action is ...

InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and know...

D-Pharm Business Development Unit US

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company has developed two unique platform technologies that generate lipid–like medicines which utilise lipid specific mechanisms and lipid-related pathways in living cells. The Company’s drug candi...

Complexa, Inc.

Complexa, Inc. is a platform biopharmaceutical company researching and developing endogenous human cell signaling technologies targeting an array of prevalent inflammatory and metabolic diseases. The company’s proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/func...

PSF biotech AG

PSF biotech (the protein structure factory™) combines state-of-the-art expertise and resources for structure supported drug discovery. Based on our high throughput crystallography platform we offer comprehensive services for lead optimization, structural target validation and characterization of protein drugs. Also we produce active, properly folded protein (high grade) with labels according to ...

GeNeuro

GeNeuro is a Swiss-based company created by Eclosion in 2006 as a spin-off of bioMérieux and co-funded by Eclosion and the Institut Mérieux. GeNeuro is developing first-in-class therapies against diseases associated with human endogenous retroviruses expression. Its lead product GNbAC1 targets MSRV-ENV protein closely linked to the onset and developm...

Incubator Interactive

Search Engine Optimization - Search Engine Marketing offered at Incubator Interactive is an effective online marketing service that will bring targeted (Relevant) visitors from Search Engines to your online business. Optimization for search engines or SEO is a fundamental part of any online promotional strategy. SEO goes beyond simply submitting your site to the search engines, and works on a numb...

ReVision Therapeutics Inc.

ReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small molecule drug for the treatment and prevention of the dry form of age-related macular degeneration (AMD). Fenretinide (RT-101), ReVision's lead drug candidate, has been evaluated in a Phase 2b clinical trial in patients with geographic atrophy, the most advanced form of dry AMD. Analysis of the end-of-st...

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a spin-off company from the Max Delbrück Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids, that have the potential to treat inflammatory, cardiovascular, and other diseases. Epoxyeicosanoids as a newly desc...

SiteSpect, Inc.

SiteSpect provides the world's only non-intrusive optimization platform, enabling web and mobile marketers to significantly improve key metrics such as conversion rate and engagement. SiteSpect's solutions include rapid A/B testing, multivariate testing, behavioral targeting and personalization, landing page optimization, mobile web optimiz...

Synvista Therapeutics, Inc.

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione pero...

Lipid Sciences

Lipid Sciences, Inc. (LIPD) is a development-stage biotechnology company that is researching and developing products and processes to treat major medical indications such as cardiovascular disease, HIV and other viral infections in which lipids or fat components play a key role. LIPD's technologies are based on a patented process that selectively and rapidly removes lipids from proteins circulatin...

Cell Culture Solutions, LLC

culture protocol, techniques, techniqe, mamalian, mammalian, protocol, expertise, bioprocessing, cellular bioprocessing, process development, upstream process development, processes development, processes development, process, process optimization, cellular process optimization, solution, contract development, contract development company, contract R&D, contract R&D company, contract company, cont...

OMEICOS Therapeutics

OMEICOS Therapeutics is a spin-off company from the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. The company has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat inflammatory, cardiovascular and other diseases. Epoxyeicosanoids, as a newly describ...

Midwest Bio Services, LLC

Midwest Bio Services, LLC is dedicated to providing reliable and affordable services in the areas of protein expression, protein purification and analytical characterization of proteins and peptides.Since the opening of our mass spectrometry facility in Overland Park, Kansas in May 2004, we have provided protein identification and characterization services to more than 150 academic research labora...

Malvern Instruments Ltd

Malvern Instruments is a global company that develops, manufactures and markets advanced analytical systems for the characterization of a wide variety of materials, from bulk powders to nanomaterials and delicate macromolecules. Innovative technologies combined with powerful software produce systems that deliver industrially relevant particle characterization, rheological and chemical composition ...

VAP Diagnostics Lab

VAP Diagnostics Lab is a new, independent reference laboratory focused solely on the comprehensive VAP®+ Lipid Panel and related cardiometabolic test panels. Using direct (not estimated) measurement, VAP+ identifies cholesterol, triglyceride and genetic lipid disorders, enabling health care professionals to accurately stratify cardiovascular risk and re...

National Lipid Association (NLA)

The National Lipid Association


More From BioPortfolio on "Characterization optimization endogenous lipid accumulation Chlorella vulgaris SDEC"

Quick Search

Corporate Database Quicklinks